Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AstraZeneca PLC (AZN)

47.37   -0.45 (-0.94%) 11-14 16:00
Open: 47.45 Pre. Close: 47.82
High: 47.51 Low: 47.11
Volume: 1,491,636 Market Cap: 122193M
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 47.566 - 47.816 47.816 - 48.029
Low: 46.517 - 46.805 46.805 - 47.051
Close: 46.898 - 47.386 47.386 - 47.801

Technical analysis

as of: 2019-11-14 4:27:22 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 57.49     One year: 67.15
Support: Support1: 45.71    Support2: 43.54
Resistance: Resistance1: 49.22    Resistance2: 57.49
Pivot: 47.69
Moving Average: MA(5): 47.28     MA(20): 46.94
MA(100): 44.02     MA(250): 41.14
MACD: MACD(12,26): 0.72     Signal(9): 0.83
Stochastic oscillator: %K(14,3): 48.33     %D(3): 54.14
RSI: RSI(14): 57.21
52-week: High: 49.22  Low: 35.30  Change(%): 14.4
Average Vol(K): 3-Month: 321119  10-Days: 292301

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AZN has closed above bottom band by 38.2%. Bollinger Bands are 27.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 15 Nov 2019 07:23:47 +0000
AstraZeneca: European Commission Approves Qtrilmet For Type-2 Diabetes

Thu, 14 Nov 2019 07:33:28 +0000
AZN:FDA Accepts Regulatory Submission For Selumetinib In Neurofibromatosis Type1

Tue, 12 Nov 2019 08:08:56 +0000
AstraZeneca Reports Positive TULIP 2 Trial For Anifrolumab To Treat SLE

Mon, 11 Nov 2019 16:04:42 +0000
Here’s Why FibroGen’s Stock Popped Friday

Mon, 11 Nov 2019 07:29:29 +0000
AstraZeneca: Roxadustat Phase III Pooled Analyses Show Positive Efficacy

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2620.00
Shares Float (M) 2620.00
% Held by Insiders 0.01
% Held by Institutions 19.37
Shares Short (K) 13510
Shares Short P. Month (K)

Stock Financials

EPS 0.800
Book Value (p.s.) 4.640
PEG Ratio 1.53
Profit Margin 8.52
Operating Margin 6.09
Return on Assets (ttm) 1.5
Return on Equity (ttm) 14.4
Qtrly Rev. Growth 20.0
Gross Profit (p.s.) 6.714
Sales Per Share
EBITDA (p.s.) 1.615
Qtrly Earnings Growth -30.60
Operating Cash Flow (M) 3820.00
Levered Free Cash Flow (M) 5830.00

Stock Valuations

P/E 59.21
P/E Growth Ratio -0.01
P/BV 10.21
P/S 5.06
P/CF 32.49

Dividends & Splits

Dividend 2.800
Dividend Yield 0.06
Dividend Pay Date 2019-09-09
Ex-Dividend Date 2019-08-08
Forward Dividend 1.400
Last Split Date 2015-07-27
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.